Caldwell Trust’s Core Laboratories CLB Stock Holding History

Caldwell Trust’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-700	Closed	-$14.2K	–	733
2020 Q2	$14.2K	Hold	700	–	–	﹤0.01%	585
2020 Q1	$7.24K	Hold	700	–	–	﹤0.01%	669
2019 Q4	$26.4K	Buy	+700	New	+$31.5K	﹤0.01%	554

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caldwell Trust's CLB Position: Q3 2020 in Review

Caldwell Trust sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 700 shares — an estimated $14.2K sold.

Caldwell Trust first reported a position in CLB in Q4 2019 and held it in 3 quarters. The position peaked at $26.4K in Q4 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

Caldwell Trust reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
Caldwell Trust sold 700 Core Laboratories shares in Q3 2020, an estimated $14.2K.
Caldwell Trust first reported a position in Core Laboratories in Q4 2019 and held it in 3 quarters.
Caldwell Trust's Core Laboratories position peaked at $26.4K in Q4 2019.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Caldwell Trust's 13F filing for Q3 2020, filed 2 Oct 2025.